Tackling diabetes & ALS with cell therapyIsraeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells Share XTackling diabetes & ALS with cell therapyhttps://pharmaphorum.com/views-and-analysis/tackling-diabetes-als-with-cell-therapy/
